Search

everythinglearnresearchcommunity

for

Search:↓

Lipid Accumulation Product and Free Androgens Index are effective for assessing fatty liver disease risk in women with Polycystic Ovary Syndrome.

Some lesser-known causes of PCOS include autoimmune issues, genetic mutations, and changes in the body's microbiome.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Pioglitazone improved insulin sensitivity and altered cortisol metabolism in PCOS patients.

Hispanic women with PCOS are more likely to have liver diseases like NAFLD and NASH.

Polycystic Ovary Syndrome (PCOS) affects Iranian women's feelings of femininity and self-image.

Vertical sleeve gastrectomy improved metabolism, behavior, and reproduction in obese rats with PCOS.

Girls with PCOS have higher levels of certain androgens, which are linked to excess hair growth, but these androgens don't help diagnose PCOS.

Women with persistent acne and high levels of antimullerian hormone are more likely to have polycystic ovarian syndrome.

Women with Polycystic Ovary Syndrome (PCOS) often have higher levels of anxiety and depression, especially if they live in rural areas, have less education, don't have children, are over 30, or are obese.

Antiandrogenic pretreatment for women with PCOS does not improve fertility outcomes and delays pregnancy.

Oxidative stress and immune dysfunction are linked to both Hashimoto's thyroiditis and polycystic ovary syndrome, with diet and specific treatments important for managing these conditions.

Sons of mothers with polycystic ovary syndrome (PCOS) have a higher risk of obesity and insulin resistance, possibly due to certain genes and factors passed down from their mothers.

Kelulut Honey can help regulate sex hormone receptors in rats with Polycystic Ovary Syndrome, similar to common medications.

Brown Adipose Tissue (BAT) could potentially treat Polycystic Ovary Syndrome (PCOS) by controlling energy balance and lipid homeostasis, but more human research is needed.

Myo-inositol plus α-lactalbumin works better than myo-inositol alone for improving symptoms of PCOS.

The conclusion is that PCOS is a common cause of hirsutism in young obese women, and early treatment is important to reduce the risk of metabolic syndrome.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

New treatments for PCOS focus on managing symptoms and improving fertility.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Ovulation disorders are a major cause of infertility and menstrual problems in women.

PCOS is a major cause of infertility in women of childbearing age.

A young woman with kidney failure had hair loss due to a common hormonal disorder, which improved with hormone therapy.

Most women with excessive hair growth have a hormonal cause.

Androgenetic alopecia involves genetics, hormones, and can be treated with medications or surgery.

Myo-inositol may be more effective than metformin for inducing ovulation in women with PCOS.